miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer

Molecular Cancer (2014) - Comments
pubmed: 24655723 doi: 10.1186/1476-4598-13-71 issn: 1476-4598

Claire Corcoran, Sweta Rani, Susan Breslin, Martina Gogarty, Irene M Ghobrial, John Crown, Lorraine O'Driscoll